Telix Pharmaceuticals Limited (ASX:TLX) Receives FDA Approval for Gozellix®
Telix Pharmaceuticals (ASX:TLX) announces FDA approval for Gozellix®, expanding prostate cancer imaging access in the U.S.
Tag: Industry-Specific News
Paladin Energy Ltd (ASX:PDN) Suspends Operations at Langer Heinrich Mine
Paladin Energy Ltd (ASX:PDN) temporarily suspends operations at Langer Heinrich Mine due to unseasonal heavy rains impacting access and production.
AIC Mines (ASX:A1M) Commences Drilling at Jericho Copper Deposit
AIC Mines (ASX:A1M) begins drilling at Jericho Copper Deposit, significantly expanding resources and exploration efforts in Queensland.
Golden Cross Resources (ASX:GCR) Completes Copper Hill Gravity Survey
Golden Cross Resources (ASX:GCR) completes a gravity survey at Copper Hill Tenement, enhancing exploration for copper-gold mineralisation.
Dreadnought Resources Ltd (ASX:DRE) Consolidates Further Gold Ground at Mangaroon
Dreadnought Resources (ASX:DRE) expands Mangaroon Gold Project by acquiring E09/2479, enhancing gold exploration prospects.
Strategic Energy Resources (ASX:SER) Secures Bulimba Gold Project
Strategic Energy Resources (ASX:SER) secures the Bulimba Gold Project in NE Queensland, targeting significant gold deposits.
Prospect Resources Limited (ASX:PSC) Identifies High-Priority Drill Target at Nyungu South
Prospect Resources (ASX:PSC) identifies a high-priority drill target at Nyungu South, enhancing exploration prospects at the Mumbezhi Copper Project.
Artemis Resources (ASX:ARV) Completes Phase One Drilling at Carlow Tenement
Artemis Resources (ASX:ARV) completes initial drilling phase at Carlow Tenement, testing high-priority gold targets with promising geological findings.
Qoria (ASX:QOR) Secures Strategic Partnership with Ohio Education Council
Qoria (ASX:QOR) secures a strategic partnership with Ohio Education Computer Network to enhance student safety and wellbeing services statewide.
Rhythm Biosciences Ltd (ASX:RHY) Records First Commercial Sales of geneType Products
Rhythm Biosciences (ASX:RHY) records its first commercial sales of geneType products, anticipating growth throughout the year.